Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)

Clinical trial NCT00337428 · COMPLETED

Trial details

NCT number: NCT00337428
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Glandular and Epithelial Diphtheria Tetanus Whooping Cough Poliomyelitis

Start date: 2006-05-01
Primary completion: 2007-05-01
Enrollment: 843

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.